BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 17638958)

  • 1. Acute decompensated heart failure.
    Nemeth J
    CMAJ; 2007 Jul; 177(2):175; author reply 175-6. PubMed ID: 17638958
    [No Abstract]   [Full Text] [Related]  

  • 2. Role of tolvaptan in acute decompensated heart failure.
    Ho JE; Teerlink JR
    Expert Rev Cardiovasc Ther; 2008 Jun; 6(5):601-8. PubMed ID: 18510477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute decompensated heart failure.
    Smithline HA
    CMAJ; 2007 Jul; 177(2):175; author reply 175-6. PubMed ID: 17638957
    [No Abstract]   [Full Text] [Related]  

  • 4. Utility of daily diuretic orders for identifying acute decompensated heart failure patients for quality improvement.
    Campbell PT; Tremaglio J; Bhardwaj A; Ryan J
    Crit Pathw Cardiol; 2010 Sep; 9(3):148-51. PubMed ID: 20802268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The rationale and indications for angiotensin receptor blockers in heart failure.
    Bybee KA; Das S; O'Keefe JH
    Heart Fail Clin; 2006 Jan; 2(1):81-8. PubMed ID: 17386879
    [No Abstract]   [Full Text] [Related]  

  • 6. A randomized, controlled trial of the renal effects of ultrafiltration as compared to furosemide in patients with acute decompensated heart failure.
    Rogers HL; Marshall J; Bock J; Dowling TC; Feller E; Robinson S; Gottlieb SS
    J Card Fail; 2008 Feb; 14(1):1-5. PubMed ID: 18226766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-dose nitroglycerin improves microcirculation in hospitalized patients with acute heart failure.
    den Uil CA; Lagrand WK; Spronk PE; van der Ent M; Jewbali LS; Brugts JJ; Ince C; Simoons ML
    Eur J Heart Fail; 2009 Apr; 11(4):386-90. PubMed ID: 19211570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of severe decompensated heart failure with high-dose intravenous nitroglycerin: a feasibility and outcome analysis.
    Levy P; Compton S; Welch R; Delgado G; Jennett A; Penugonda N; Dunne R; Zalenski R
    Ann Emerg Med; 2007 Aug; 50(2):144-52. PubMed ID: 17509731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intermittent inotropic infusions combined with prophylactic oral amiodarone for patients with decompensated end-stage heart failure.
    Drakos SG; Kanakakis JV; Nanas S; Bonios M; Kaldara E; Katsaros F; Pantsios C; Nanas JN
    J Cardiovasc Pharmacol; 2009 Feb; 53(2):157-61. PubMed ID: 19188832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Timing of immunoreactive B-type natriuretic peptide levels and treatment delay in acute decompensated heart failure: an ADHERE (Acute Decompensated Heart Failure National Registry) analysis.
    Maisel AS; Peacock WF; McMullin N; Jessie R; Fonarow GC; Wynne J; Mills RM
    J Am Coll Cardiol; 2008 Aug; 52(7):534-40. PubMed ID: 18687247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute congestive heart failure in the emergency department.
    Rogers RL; Feller ED; Gottlieb SS
    Cardiol Clin; 2006 Feb; 24(1):115-23, vii. PubMed ID: 16326261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Substantial Discrepancy Between Fluid and Weight Loss During Acute Decompensated Heart Failure Treatment.
    Testani JM; Brisco MA; Kociol RD; Jacoby D; Bellumkonda L; Parikh CR; Coca SG; Tang WH
    Am J Med; 2015 Jul; 128(7):776-83.e4. PubMed ID: 25595470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peripartum cardiomyopathy: a new successful setting for levosimendan.
    Benezet-Mazuecos J; de la Hera J
    Int J Cardiol; 2008 Jan; 123(3):346-7. PubMed ID: 17324479
    [No Abstract]   [Full Text] [Related]  

  • 14. [Drug treatment of heart failure].
    Kettunen R
    Duodecim; 2005; 121(11):1239-48. PubMed ID: 15999983
    [No Abstract]   [Full Text] [Related]  

  • 15. [Therapeutic effect of recombinant human brain natriuretic peptide for treatment of decompensated heart failure: comparison with nitroglycerin].
    Xie CL; Meng SR; Wang W; Chen SM; Li P; Feng XG
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 May; 28(5):839-42. PubMed ID: 18504215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta-blockers: essential heart failure therapy.
    Ginsberg F
    Crit Care Med; 2011 May; 39(5):1198-9. PubMed ID: 21610573
    [No Abstract]   [Full Text] [Related]  

  • 17. [Intravenous molsidomine administration in heart failure. Part II: Comparison with nitroglycerin and effectiveness in nitrate tolerance].
    Störk T; Möckel M; Danne O; Müller R; Eichstädt H; Hochrein H
    Med Klin (Munich); 1994 Jul; 89 Suppl 2():50-3. PubMed ID: 7968904
    [No Abstract]   [Full Text] [Related]  

  • 18. Subcutaneous infusion of furosemide administered by elastomeric pumps for decompensated heart failure treatment: initial experience.
    Zatarain-Nicolás E; López-Díaz J; de la Fuente-Galán L; García-Pardo H; Recio-Platero A; San Román-Calvar JA
    Rev Esp Cardiol (Engl Ed); 2013 Dec; 66(12):1002-4. PubMed ID: 24774118
    [No Abstract]   [Full Text] [Related]  

  • 19. Vasopressin antagonists in the management of heart failure.
    Rossi J; Orlandi C; Gheorghiade M
    Expert Rev Cardiovasc Ther; 2007 Mar; 5(2):323-30. PubMed ID: 17338675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Acute therapy of heart failure with nitroglycerin. Rapid help in routine practice].
    Bussmann WD
    MMW Fortschr Med; 2001 Apr; 143(17):45. PubMed ID: 11490508
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.